Skip to content
akaturk Academic measurement
Sign in Sign up

Academician

TOLGA SÜTLÜ

Doktor Öğretim Üyesi

Acıbadem Mehmet Ali Aydınlar Üniversitesi

Research topics OpenAlex
Articles 25 YÖKSİS 25 · OpenAlex 0 Total citations 2,006 h-index 16 · OpenAlex OpenAlex coverage %96 matched 24 / 25 Q1 articles 16 Scopus · WoS Q1 14 Co-authors 29 7 Turkish institutions

Citation impact

Citation counts of the articles matched in OpenAlex, citing publications from Crossref and the Stanford/Elsevier list. Sources are shown separately and never added up.

OpenAlex YÖKSİS articles matched in OpenAlex: 24 + YÖKSİS · co-author record: 1
h-index 16 Percentile in Türkiye: 95 #34 of 397 at their university by h-index
i10-index
18
Total citations
2,006
Top 1.7% in Türkiye
Per article
80.2
FWCI
3.77
1.00 = world average
World top 1%
2
World top 10%
9

Most cited articles

  1. Tracheobronchial transplantation with a stem-cell-seeded bioartificial nanocomposite: a proof-of-concept study 2011 world top 1% 426 citations
  2. Delivery of short interfering RNA using endosomolytic cell-penetrating peptides 2007 world top 1% 324 citations
  3. Natural killer cell-based immunotherapy in cancer: current insights and future prospects 2009 world top 10% 202 citations
How is this computed?

h-index and citations are computed from the citation counts of this academic’s YÖKSİS articles matched in OpenAlex (not Google Scholar, WoS or Scopus). Unmatched articles are not included. 1 articles (1 citations) tagged with this academic’s YÖK author id in co-authors’ YÖKSİS records count only towards citations, h-index and i10; article counts, percentiles and rankings use their own YÖKSİS list.

Citing publications Crossref 323 publications citing 25 DOI-bearing articles · 12 Türkiye-affiliated
  • 2016 1
  • 2018 9
  • 2019 65
  • 2020 94
  • 2021 103
  • 2022 30
  • 2023 2
  • 2025 16
  • 2026 3
  1. DOI 10.1016/j.cytogfr.2025.12.008 2026
  2. DOI 10.1182/bloodadvances.2025018133 2026 · cites 2 articles of this academic
  3. DOI 10.1016/j.jcyt.2025.10.004 2026 · cites 2 articles of this academic
  4. DOI 10.61882/ijbc.17.3.79 2025
  5. DOI 10.23873/2074-0506-2025-17-4-504-514 2025
  6. DOI 10.1002/advs.202516852 2025
  7. DOI 10.1038/s42003-025-09277-0 2025
  8. DOI 10.3389/fphar.2025.1738558 2025
  9. DOI 10.1101/2025.11.26.690657 2025
  10. DOI 10.2147/ijn.s529791 2025
  11. DOI 10.3389/fimmu.2025.1608277 2025
  12. DOI 10.1016/j.isci.2025.114079 2025
  13. DOI 10.1186/s12935-025-03980-y 2025
  14. DOI 10.3389/fmicb.2025.1720153 2025
  15. DOI 10.20935/acadonco7986 2025
  16. DOI 10.1093/immadv/ltaf036 2025
  17. DOI 10.3390/microorganisms13122687 2025
  18. DOI 10.1080/17425247.2025.2587940 2025
  19. DOI 10.3389/fimmu.2025.1686880 2025
  20. Aptamer-based Emerging Tools for Viral Biomarker Detection: A Focus on SARS-CoV-2 TR Prabir Kumar Kulabhusan et al. · Current Medicinal Chemistry · 2023
  21. DOI 10.4018/978-1-6684-7412-9.ch009 2023
  22. Autologous NK cells as consolidation therapy following stem cell transplantation in multiple myeloma TR Hareth Nahi et al. · Cell Reports Medicine · 2022 · cites 3 articles of this academic
  23. Targeting Apoptosis to Overcome Chemotherapy Resistance TR Eda Dogan et al. · Metastasis · 2022
  24. Application of Nanomaterials in Food Quality Assessment TR Milad Torabfam et al. · Nanosensing and Bioanalytical Technologies in Food Quality Control · 2022
  25. DOI 10.51847/0mz81d1ojh 2022
  26. DOI 10.1016/j.ejphar.2022.174822 2022
  27. DOI 10.1371/journal.pone.0264897 2022
  28. DOI 10.3389/fimmu.2022.825979 2022 · cites 3 articles of this academic
  29. DOI 10.1080/16078454.2022.2029256 2022
  30. DOI 10.3390/biomedicines10020400 2022

Showing the 30 most recent.

Where does this list come from?

Extracted from the reference lists in Crossref’s public March 2026 data file; 20.3% of the file has been processed, so the list may be incomplete. Crossref citations are never added to or compared with the OpenAlex citation counts; the two sources have different coverage.

Works 25

YÖKSİS and OpenAlex records: index distribution, journals published in, a filterable article list and the other output types.

Indexes and citation percentiles

?
TR Index 1 articles
OpenAlex citation percentile
Top 1%2
Top 10%9
Avg · n 28 %73.9
Other counts

Scopus (SJR)

  • YÖKSİS rows 27

WoS (JCR)

  • YÖKSİS rows 27

Articles

Articles with YÖKSİS and OpenAlex source split; narrow by quartile or TR Index.

25articles

Journals with publications

21 journals

Narrow down

Scopus (SJR)
Q116 Q25 Q32 Q40
WoS (JCR)
Q114 Q24 Q34 Q41
TR Index
1articles

Article list

  1. 2023 TCR-NK Cells: A Novel Source for Adoptive Immunotherapy of Cancer Turkish Journal of Hematology DOI 10.4274/tjh.galenos.2022.2022.0534 YÖKSİS TR Index SJR Q3 JCR Q3 OpenAlex 52.5%
  2. 2022 Decline of humoral immune responses after natural SARS-CoV-2 infection can be efficiently reversed by vaccination. Canadian Journal of Microbiology DOI 10.1139/cjm-2022-0003 5 YÖKSİS records YÖKSİS SJR Q2 JCR Q3 OpenAlex 48.1%
  3. 2022 Human immunodeficiency virus type 1 impairs sumoylation. Life Sci Alliance DOI 10.26508/lsa.202101103 YÖKSİS SJR Q1 JCR Q1 OpenAlex 58.4%
  4. 2020 Boosting Natural Killer Cell-Mediated Targeting of Sarcoma Through DNAM-1 and NKG2D. Frontiers in immunology DOI 10.3389/fimmu.2020.00040 YÖKSİS OpenAlex top 10% OpenAlex 92.4%
  5. 2019 Plasmonic Selection of ssDNA Aptamers against Fibroblast Growth Factor Receptor American Chemical Society (ACS) DOI 10.1021/acscombsci.9b00059 YÖKSİS SJR Q1 JCR Q1 OpenAlex 73.3%
  6. 2019 Engineering antigen‐specific NK cell lines against the melanoma‐associated antigen tyrosinase via TCR gene transfer Wiley DOI 10.1002/eji.201948140 YÖKSİS SJR Q1 JCR Q2 OpenAlex top 10% OpenAlex 90.4%
  7. 2019 Myeloid maturation potentiates STAT3-mediated atypical IFN-γ signaling and upregulation of PD-1 ligands in AML and MDS Scientific Reports DOI 10.1038/s41598-019-48256-4 YÖKSİS SJR Q1 JCR Q1 OpenAlex 86.7%
  8. 2015 Deletion of Chromosomal Region 8p21 Confers Resistance to Bortezomib and Is Associated with Upregulated Decoy TRAIL Receptor Expression in Patients with Multiple Myeloma PLOS ONE DOI 10.1371/journal.pone.0138248 YÖKSİS SJR Q1 JCR Q1 OpenAlex 70.5%
  9. 2014 Splice-correcting oligonucleotides restore BTK function in X-linked agammaglobulinemia model Journal of Clinical Investigation DOI 10.1172/JCI76175 YÖKSİS SJR Q1 JCR Q1 OpenAlex 85.7%
  10. 2013 In search of the molecular consequences of 8p21 deletion in multiple myeloma: commentary on Gmidéne et al Medical Oncology DOI 10.1007/s12032-013-0569-9 YÖKSİS SJR Q1 JCR Q3 OpenAlex 54.5%
  11. 2012 Inhibition of Intracellular Antiviral Defense Mechanisms Augments Lentiviral Transduction of Human Natural Killer Cells: Implications for Gene Therapy Human Gene Therapy DOI 10.1089/hum.2012.080 YÖKSİS SJR Q2 JCR Q1 OpenAlex top 10% OpenAlex 90.2%
  12. 2011 Clinical impact of chromosomal aberrations in multiple myeloma Journal of Internal Medicine DOI 10.1111/j.1365-2796.2010.02324.x YÖKSİS SJR Q1 JCR Q1 OpenAlex 87.2%
  13. 2011 Tracheobronchial transplantation with a stem-cell-seeded bioartificial nanocomposite: a proof-of-concept study The Lancet DOI 10.1016/S0140-6736(11)61715-7 YÖKSİS SJR Q1 JCR Q1 OpenAlex top 1% OpenAlex 99.9%
  14. 2011 Ex vivo expansion of natural killer cells: a question of function Cytotherapy DOI 10.3109/14653249.2011.563295 YÖKSİS SJR Q2 JCR Q1 OpenAlex 58.7%
  15. 2010 Suicide gene therapy for graft-versus-host disease IMMUNOTHERAPY DOI 10.2217/IMT.1019 YÖKSİS
  16. 2010 Constitutional inv(3) in myelodysplastic syndromes Leukemia Research DOI 10.1016/j.leukres.2010.05.014 YÖKSİS SJR Q2 JCR Q2 OpenAlex 48.7%
  17. 2010 Clinical-grade, large-scale, feeder-free expansion of highly active human natural killer cells for adoptive immunotherapy using an automated bioreactor Cytotherapy DOI 10.3109/14653249.2010.504770 YÖKSİS SJR Q2 JCR Q2 OpenAlex 89.5%
  18. 2009 Natural killer cell-based immunotherapy in cancer: current insights and future prospects Journal of Internal Medicine DOI 10.1111/j.1365-2796.2009.02121.x YÖKSİS SJR Q1 JCR Q1 OpenAlex top 10% OpenAlex 96.9%
  19. 2009 The prognostic significance of 8p21 deletion in multiple myeloma British Journal of Haematology DOI 10.1111/j.1365-2141.2008.07454.x YÖKSİS SJR Q1 JCR Q1 OpenAlex 65.2%
  20. 2009 Safety analysis of ex vivo-expanded NK and NK-like T cells administered to cancer patients: a Phase I clinical study Immunotherapy DOI 10.2217/IMT.09.47 YÖKSİS SJR Q3 JCR Q4 OpenAlex top 10% OpenAlex 91.0%

Projects 7 See all (7) →

  1. 2025 Kanser İmmünoterapisi için Doğal Öldürücü Hücrelerin Sitotoksik Aktivitesinin Genetik Modifikasyonlar ile Geliştirilmesi Yükseköğretim Kurumları tarafından destekli bilimsel araştırma projesi · Tamamlandı 2025-02-27 – 2026-06-23
  2. 2020 COVID-19 konvelasan plazma vericilerinde oluşan antikor etkinliğinin belirlenmesi için psödovirüse dayalı nötralizasyon testi geliştirilmesi Yükseköğretim Kurumları tarafından destekli bilimsel araştırma projesi · Tamamlandı 2020-11-02 – 2021-11-02
  3. 2021 Protein-Protein Bağlantısını Kontrol Eden Nanobodilerin Keşfi -Tübitak 1001 · Tamamlandı 2021-05-26 – 2022-12-07
  4. 2021 Pediatrik B Hücreli Akut Lenfoblastik Lösemide Hücre Dışı Veziküllerin Anti-Lösemi İmmünitesi Üzerine Etkileri -Tübitak 1002 · Tamamlandı 2021-11-15 – 2022-11-15
  5. 2015 Kanser İmmünoterapisi Hedef Moleküllerinin Keşfi İçin Hücresel Düzeyde Bir Tarama Testi -Tübitak 1001 · Tamamlandı 2015-04-15 – 2018-10-15

Proceedings 14 See all (14) →

  1. 2019 STAT3-mediated atypical IFN-gamma signaling modulates the PD-1 ligands in CD11b-positive subpopulation of MDS and AML cells 17th International Congress of Immunology of the International-Union-of-Immunological-Societies (IUIS)
  2. 2018 FOCUSED ELECTRON AND ION BEAM (FEB-FIB) MODIFICATION OF BIOCERAMIC SURFACES FOROSTEOBLAST CELLS ADHESION OPTIMIZATION 27. International Materials Congress-IMRC
  3. 2022 DENEYSEL OTOİMMÜN ENSEFALOMİYELİT (EAE) FARE MODELİNDE FARKLI YAKLAŞIMLARLA OLUŞTURULAN TOLEROJENİK DENDRİTİK HÜCRE BAZLI TEDAVİLERİN MONOSİTİK/GRANÜLOSİTİK VE T HÜCRE YANITLARI ÜZERİNE ETKİLERİ 12. KLİNİK NÖROİMMÜNOLOJİ SEMPOZYUMU
  4. 2017 Silencing of CD80 and CD86 on the surface of RAW 264.7 cells via CRISP/Cas9 World Immune Regulation Meeting XII
  5. 2019 Genetic modification strategies of the dendritic cells for the induction of immune tolerance in collagen-induced arthritis (CIA) mouse model International Molecular Immunology and Immunogenetıcs Congress IV (MIMIC IV)

Patents 1

  1. — Enhanced gene delivery to natural killer cells, hematopoietic stem cells and macrophages EP3356524B1

← Back to academicians

Collaboration network

From the author lists of YÖKSİS publication records. Duplicate records of a work count once; institutions are co-authors’ current YÖKSİS affiliations.

Co-authors
29
With an akaturk profile
17
Turkish institutions
7
Co-authored works
%24

Academic co-authors 17

  1. ALİ RİZA UMUT ŞAHİN Doçent · Sabancı Üniversitesi 1
  2. BİLGÜL METE Profesör · İstanbul Üniversitesi-Cerrahpaşa 1
  3. DİĞDEM YÖYEN ERMİŞ Doçent · Bursa Uludağ Üniversitesi 1
  4. ELİF ÖZSOY Doktor Öğretim Üyesi · Erzincan Binali Yıldırım Üniversitesi 1
  5. ERDEM TÜZÜN Profesör · İstanbul Üniversitesi 1
  6. FATMA BETÜL ÖKTELİK Araştırma Görevlisi · İstanbul Üniversitesi 1
  7. GÜNEŞ ESENDAĞLI Profesör · Hacettepe Üniversitesi 1
  8. GÜNNUR DENİZ Profesör · İstanbul Üniversitesi 1
  9. HASAN KURT Doçent · İstanbul Medipol Üniversitesi 1
  10. MEHMET BATU ERMAN Profesör · Acıbadem Mehmet Ali Aydınlar Üniversitesi same university 1
Show all (17)
  1. MERAL YÜCE KURT Doktor Öğretim Üyesi · Sabancı Üniversitesi 1
  2. METİN YUSUF GELMEZ Doçent · İstanbul Üniversitesi 1
  3. MURAT KÖSE Profesör · İstanbul Üniversitesi 1
  4. NİLGÜN AKDENİZ Doktor Öğretim Üyesi · İstanbul Üniversitesi 1
  5. VUSLAT YILMAZ Profesör · İstanbul Üniversitesi 1
  6. YAHYA BÜYÜKAŞIK Profesör · Hacettepe Üniversitesi 1
  7. ÖMER FEHMİ TABAK Profesör · İstanbul Üniversitesi-Cerrahpaşa 1

National collaboration 7 institutions

Within own university1 joint works · Acıbadem Mehmet Ali Aydınlar Üniversitesi

  1. Sabancı Üniversitesi 2 works · 2 academics
  2. Bursa Uludağ Üniversitesi 1 works · 1 academics
  3. Erzincan Binali Yıldırım Üniversitesi 1 works · 1 academics
  4. Hacettepe Üniversitesi 1 works · 2 academics
  5. İstanbul Medipol Üniversitesi 1 works · 1 academics
  6. İstanbul Üniversitesi 1 works · 7 academics
  7. İstanbul Üniversitesi-Cerrahpaşa 1 works · 2 academics

Other co-authors (incl. international) 12

Alp Ertunga EyüpoğluBilgenur BilgeCEVRİYE PAMUKCUDİDEM ÖZKAZANÇ ÜNSALECE TAVUKÇUOĞLUEMRE PEKBİLİRGÜRCAN TUNALIHİKMET BUDAKMertkaya ArasPanagiota GeorgiadouUTKU HORZUMZEYNEP SENA KARAHAN

Authors without an akaturk profile (international researchers, retired or former academics, students, clinicians) are grouped by name spelling; short forms such as “Gulluce M.” join the single full name they match.